Search Results
You are looking at 1 - 4 of 4 items for
- Author: Eun Jig Lee x
- Refine by access: All content x
Search for other papers by Eun Jig Lee in
Google Scholar
PubMed
Search for other papers by J Larry Jameson in
Google Scholar
PubMed
Despite a stuttering course, gene therapy continues to provide a potential treatment avenue for many human diseases, including cancer and various inherited disorders. Gene therapy is also attractive for the treatment of local, benign disorders, such as pituitary adenomas. Advances in technology have focused on modifying existing viral vectors and developing targeted expression of therapeutic genes in an effort to achieve efficacy with minimal toxicity. Gene therapy also offers innovative strategies for treating hypopituitarism by replacing hormones such as growth hormone (GH) and vasopressin.
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Search for other papers by Yongho Lee in
Google Scholar
PubMed
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Search for other papers by Jeong Mo Kim in
Google Scholar
PubMed
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Department of Internal Medicine, Graduate School, Brain Korea 21 Project for Medical Science, Institute of Endocrine Research, Endocrinology, Biochemistry and Molecular Biology
Search for other papers by Eun Jig Lee in
Google Scholar
PubMed
The interaction of chemokine (C-X-C motif) ligand 12 (CXCL12) and its receptor CXCR4 may play an important role in the regulation of anterior pituitary function. In this study, we investigated the expression of CXCL12 and CXCR4 and their role in normal rat pituitary and GH-producing GH3 tumor cell line. RT-PCR analysis and immunohistochemistry revealed that CXCR4 was expressed in normal rat anterior pituitary and GH3 tumor cells. Double immunofluorescent staining showed the complete colocalization of CXCR4 with GH in rat pituitary, indicating that CXCR4 is specifically expressed in rat somatotrophs. Using rat primary pituitary cell cultures and GH releasing hormone receptor expressing stable GH3 cells (GH3-GHRHR), we evaluated the function of CXCL12 compared with GHRH. CXCL12 stimulated GH gene activation in both primary rat anterior pituitary cells and GH3-GHRHR cells. CXCL12 also stimulated GH secretion from primary rat pituitary cells in a dose-dependant manner. BrdU incorporation was increased in response to CXCL12 addition in GH3 cell culture, indicating CXCL12-induced cell proliferation. CXCL12-dependent phosphorylation of ERK1/2 was also confirmed by western blot analysis, supporting the evidence that MAPK is an intracellular mediator of CXCL12/CXCR4 interaction in GH3 cell proliferation. In conclusion, these results indicate that CXCL12/CXCR4 interaction plays an important role in GH production, secretion, and the proliferation of somatotrophs.
Search for other papers by Jin Sook Yoon in
Google Scholar
PubMed
Search for other papers by Hyun Jung Lee in
Google Scholar
PubMed
Search for other papers by Min Kyung Chae in
Google Scholar
PubMed
Search for other papers by Sang Yeul Lee in
Google Scholar
PubMed
Departments of Ophthalmology, Endocrinology, Biochemistry and Molecular Biology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea
Search for other papers by Eun Jig Lee in
Google Scholar
PubMed
Cigarette smoking is known to aggravate Graves' orbitopathy (GO) severity by enhancing adipogenesis. We investigated the effect of quercetin, an antioxidant, on adipocyte differentiation induced by cigarette smoke extract (CSE) in primary cultured orbital fibroblasts (OFs) from GO patients. Freshly prepared CSE was added to the cells and H2O2 was used as a positive control. Intracellular reactive oxygen species (ROS) generation and adipogenesis were measured. The expressions of proteins peroxisome proliferator-activated receptor (PPAR) γ, CCAAT-enhancer-binding proteins (C/EBP) α and β, and heme oxygenase-1 (HO-1), an antioxidant enzyme, were examined during adipogenic differentiation. In result, CSE and H2O2 dose-dependently stimulated intracellular ROS production in normal and Graves' OFs. The effect of 2% CSE was similar to that of 10 μM H2O2; both concentrations were noncytotoxic and were used throughout the experiment. Quercetin pretreatment reduced the ROS generation stimulated by either CSE or H2O2 in preadipocyte OFs. CSE and H2O2 stimulated adipocyte differentiation in cultured OFs. The addition of quercetin (50 or 100 μM) suppressed adipogenesis. Quercetin also suppressed ROS generation in differentiating OFs during adipogenesis stimulated by CSE and H2O2. Additionally, the expressions of PPARγ, C/EBPα, and C/EBPβ proteins were reduced in the quercetin-treated OFs. Quercetin also reduced the CSE- and H2O2-induced upregulation of ROS and HO-1 protein in differentiated OFs and preadipocyte OFs. As shown in this study, quercetin inhibited adipogenesis by reducing ROS in vitro, supporting the use of quercetin in the treatment of GO.
Search for other papers by Mi Ae Cho in
Google Scholar
PubMed
Search for other papers by Mi Kyung Lee in
Google Scholar
PubMed
Search for other papers by Kee-Hyun Nam in
Google Scholar
PubMed
Search for other papers by Woung Youn Chung in
Google Scholar
PubMed
Search for other papers by Cheong Soo Park in
Google Scholar
PubMed
Search for other papers by Ju Hyeong Lee in
Google Scholar
PubMed
Search for other papers by Taewoong Noh in
Google Scholar
PubMed
Search for other papers by Woo Ick Yang in
Google Scholar
PubMed
Search for other papers by Yumie Rhee in
Google Scholar
PubMed
Search for other papers by Sung-Kil Lim in
Google Scholar
PubMed
Search for other papers by Hyun Chul Lee in
Google Scholar
PubMed
Search for other papers by Eun Jig Lee in
Google Scholar
PubMed
Medullary thyroid carcinoma (MTC) originates from parafollicular C cells. Estrogen receptor β(ERβ) expressionwas detected in normal parafollicular C cells and MTC tumor tissue, but ERα expression in MTC tumors still remains undetermined. The appearance and loss of ERα or ERβ expression has been known to play a role in the development and progression of many human cancers. We performed immunohistochemical studies of ERα, ERβ, and Ki67, a mitotic index, in 11 human MTC tissue samples. ERα was detected in 10 cases (91%), and ERβ expression was observed in 8 cases (72.7%). A majority (8/10) of ERα-positive tumors showing ERβ Ki67 expression was detected in three cases (27.3%). Neither clinical parameters nor tumor node metastasis (TNM) tumor staging was correlated with the positivity for ERs or Ki67. To investigate the biological role of each ER, we used ER-negative MTC TT cells and adenoviral vectors carrying ERα (Ad-ERα), ERβ (Ad-ERβ), estrogen response element (ERE)-Luc (Ad-ERE-Luc), and activator protein 1 (AP1)-Luc (Ad-AP1-Luc). Estrogen stimulated and anti-estrogen, ICI 182 780, suppressed ERE reporter activity in TT cells expressing ERα or ERβ, suggesting that both ERs use the same classical ERE-mediated pathway. Ad-ERα infection stimulated TT cell growth; in contrast, Ad-ERβ infection suppressed their growth. Apoptosis was detected in Ad-ERβ-infected TT cells. Estrogen and anti-estrogen suppressed AP1 activity in Ad-ERα-infected cells, whereas upon Ad-ERβ infection estrogen further stimulated AP1 activity which in turn is suppressed by anti-estrogen, suggesting that each ER acts differently through a non-ERE-mediated pathway. Our results suggest that ERα and ERβ may play different roles in MTC tumor growth and progression.
